Literature DB >> 6380687

The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules.

E Farber.   

Abstract

The biochemical properties of putative preneoplastic hepatocyte nodules as they relate to the metabolism of xenobiotics have been reviewed briefly. A common pattern with low phase I components and elevated phase II components appears evident. The phase I components included microsomal cytochromes P-450 in composite and four different mixed function oxygenase activities. The activities in the nodules were 50% or less of the control values. The phase II components included glutathione, glutathione S-transferases and UDP-glucuronyl transferase 1 and showed two- to five-fold elevations. In addition, activities of microsomal epoxide hydrolase, cytosolic DT-diaphorase, and gamma-glutamyl transferase were all elevated in nodules. The possible significance of this biochemical pattern in analyzing the diversity of biochemical expressions of cancer, in the mechanism of cancer development, and in understanding the suggested role of physiological adaptation in carcinogenesis is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6380687     DOI: 10.1139/o84-066

Source DB:  PubMed          Journal:  Can J Biochem Cell Biol        ISSN: 0714-7511


  19 in total

1.  Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene.

Authors:  G J Moffat; A W McLaren; C R Wolf
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

2.  Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil.

Authors:  S M Black; J D Beggs; J D Hayes; A Bartoszek; M Muramatsu; M Sakai; C R Wolf
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

3.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.

Authors:  C J Henderson; A G Smith; J Ure; K Brown; E J Bacon; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 4.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

5.  Preferential over-expression of the class alpha rat Ya2 glutathione S-transferase subunit in livers bearing aflatoxin-induced pre-neoplastic nodules. Comparison of the primary structures of Ya1 and Ya2 with cloned class alpha glutathione S-transferase cDNA sequences.

Authors:  J D Hayes; L A Kerr; D J Harrison; A D Cronshaw; A G Ross; G E Neal
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

6.  Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.

Authors:  J D Hayes; D J Judah; L I McLellan; L A Kerr; S D Peacock; G E Neal
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

7.  Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards.

Authors:  A D Lewis; I D Hickson; C N Robson; A L Harris; J D Hayes; S A Griffiths; M M Manson; A E Hall; J E Moss; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Inhibition of cell proliferation and glutathione S-transferase by ascorbyl esters and interferon in mouse glioma.

Authors:  A K Naidu; M Wiranowska; S H Kori; K C Roetzheim; A P Kulkarni
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

9.  Changes in the rat liver drug metabolizing system during a short thiobenzamide feeding cycle.

Authors:  E Chieli; M Saviozzi; G Malvaldi
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

Review 10.  Fumonisins: isolation, chemical characterization and biological effects.

Authors:  W C Gelderblom; W F Marasas; R Vleggaar; P G Thiel; M E Cawood
Journal:  Mycopathologia       Date:  1992-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.